{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:24:51Z","timestamp":1776533091944,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA172073"],"award-info":[{"award-number":["R01CA172073"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA211115"],"award-info":[{"award-number":["R50CA211115"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5493-8","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T16:58:17Z","timestamp":1553705897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-7391","authenticated-orcid":false,"given":"Erin J. A.","family":"Bowles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onchee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Ziebell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra P.","family":"Ritzwoller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea N.","family":"Burnett-Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Sterrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Chubak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"5493_CR1","unstructured":"American Cancer Society Facts and Figures [October 25, 2017]. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2017\/cancer-facts-and-figures-2017.pdf ."},{"key":"5493_CR2","unstructured":"SEER [October 25, 2017]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/colorect.html ."},{"key":"5493_CR3","unstructured":"Morbidity and Mortality Weekly Report [March 10, 2018]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6447a1.htm#tab1 ."},{"issue":"1","key":"5493_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4068\/cmj.2013.49.1.1","volume":"49","author":"SY Lim","year":"2013","unstructured":"Lim SY. Role of statins in coronary artery disease. Chonnam Med J. 2013;49(1):1\u20136. https:\/\/doi.org\/10.4068\/cmj.2013.49.1.1 Epub Apr 25.","journal-title":"Chonnam Med J"},{"issue":"4","key":"5493_CR5","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/sj.leu.2402476","volume":"16","author":"WW Wong","year":"2002","unstructured":"Wong WW, Dimitroulakos J, Minden MD, Penn LZ. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia. 2002;16(4):508\u201319. https:\/\/doi.org\/10.1038\/sj.leu.2402476 .","journal-title":"Leukemia."},{"issue":"1","key":"5493_CR6","first-page":"10","volume":"9","author":"KK Chan","year":"2003","unstructured":"Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res. 2003;9(1):10\u20139.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"5493_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nrc751","volume":"5","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer. 2005;5(12):930\u201342. https:\/\/doi.org\/10.1038\/nrc751 .","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"5493_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1093\/carcin\/22.8.1139","volume":"22","author":"C Denoyelle","year":"2001","unstructured":"Denoyelle C, Vasse M, Korner M, Mishal Z, Ganne F, Vannier JP, et al. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis. 2001;22(8):1139\u201348.","journal-title":"Carcinogenesis."},{"issue":"12","key":"5493_CR9","first-page":"4885","volume":"61","author":"T Kusama","year":"2001","unstructured":"Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, et al. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res. 2001;61(12):4885\u201391.","journal-title":"Cancer Res"},{"issue":"7","key":"5493_CR10","first-page":"2067","volume":"7","author":"WW Wong","year":"2001","unstructured":"Wong WW, Tan MM, Xia Z, Dimitroulakos J, Minden MD, Penn LZ. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. Clin Cancer Res. 2001;7(7):2067\u201375.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"5493_CR11","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s10620-009-0790-8","volume":"54","author":"AA Siddiqui","year":"2009","unstructured":"Siddiqui AA, Nazario H, Mahgoub A, Patel M, Cipher D, Spechler SJ. For patients with colorectal cancer, the long-term use of statins is associated with better clinical outcomes. Dig Dis Sci. 2009;54(6):1307\u201311. https:\/\/doi.org\/10.1007\/s10620-009-0790-8 Epub 2009 Apr 1.","journal-title":"Dig Dis Sci"},{"key":"5493_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/1471-2407-12-487","volume":"12","author":"F Lakha","year":"2012","unstructured":"Lakha F, Theodoratou E, Farrington SM, Tenesa A, Cetnarskyj R, Din FV, et al. Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage. BMC Cancer. 2012;12:487. https:\/\/doi.org\/10.1186\/1471-2407-12-487 .","journal-title":"BMC Cancer"},{"issue":"28","key":"5493_CR13","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1200\/JCO.2013.54.4569","volume":"32","author":"CR Cardwell","year":"2014","unstructured":"Cardwell CR, Hicks BM, Hughes C, Murray LJ. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. J Clin Oncol. 2014;32(28):3177\u201383. https:\/\/doi.org\/10.1200\/JCO.2013.54.4569 Epub 2014 Aug 4.","journal-title":"J Clin Oncol"},{"issue":"6","key":"5493_CR14","doi-asserted-by":"publisher","first-page":"djv045","DOI":"10.1093\/jnci\/djv045","volume":"107","author":"M Hoffmeister","year":"2015","unstructured":"Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, et al. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst. 2015;107(6):djv045. https:\/\/doi.org\/10.1093\/jnci\/djv045 Print 2015 Jun.","journal-title":"J Natl Cancer Inst"},{"key":"5493_CR15","doi-asserted-by":"crossref","unstructured":"Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, et al. Metabolic Dysfunction, Obesity, and Survival Among Patients With Early-Stage Colorectal Cancer. J Clin Oncol. 2016;34(30):3664-3671.","DOI":"10.1200\/JCO.2016.67.4473"},{"issue":"1","key":"5493_CR16","first-page":"11","volume":"87","author":"H Yokomichi","year":"2017","unstructured":"Yokomichi H, Nagai A, Hirata M, Tamakoshi A, Kiyohara Y, Kamatani Y, et al. Statin use and all-cause and cancer mortality: BioBank Japan cohort. J Epidemiol. 2017;87(1):11\u201320.","journal-title":"J Epidemiol"},{"issue":"12","key":"5493_CR17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/bjc.2017.139","volume":"116","author":"RT Gray","year":"2017","unstructured":"Gray RT, Loughrey MB, Bankhead P, Cardwell CR, McQuaid S, O'Neill RF, et al. Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study. Br J Cancer. 2017;116(12):1652\u20139. https:\/\/doi.org\/10.1038\/bjc.2017.139 Epub May 18.","journal-title":"Br J Cancer"},{"issue":"6","key":"5493_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/aje\/kww245","volume":"186","author":"TL Lash","year":"2017","unstructured":"Lash TL, Riis AH, Ostenfeld EB, Erichsen R, Vyberg M, Ahern TP, et al. Associations of statin use with colorectal Cancer recurrence and mortality in a Danish cohort. Am J Epidemiol. 2017;186(6):679\u201387. https:\/\/doi.org\/10.1093\/aje\/kww245 .","journal-title":"Am J Epidemiol"},{"issue":"2","key":"5493_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1053\/j.gastro.2017.05.011","volume":"153","author":"PW Voorneveld","year":"2017","unstructured":"Voorneveld PW, Reimers MS, Bastiaannet E, Jacobs RJ, van Eijk R, Zanders MMJ, et al. Statin Use After Diagnosis of Colon Cancer and Patient Survival. Gastroenterology. 2017;153(2):470\u20139.e4. https:\/\/doi.org\/10.1053\/j.gastro.2017.05.011 Epub May 13.","journal-title":"Gastroenterology"},{"issue":"20","key":"5493_CR20","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/jnci\/djr307","volume":"103","author":"K Ng","year":"2011","unstructured":"Ng K, Ogino S, Meyerhardt JA, Chan JA, Chan AT, Niedzwiecki D, et al. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst. 2011;103(20):1540\u201351. https:\/\/doi.org\/10.1093\/jnci\/djr307 Epub 2011 Aug 17.","journal-title":"J Natl Cancer Inst"},{"key":"5493_CR21","unstructured":"Centers for Disease Control and Prevention [March 23, 2018]. Available from: https:\/\/www.cdc.gov\/dhdsp\/data_statistics\/fact_sheets\/fs_heart_disease.htm ."},{"key":"5493_CR22","doi-asserted-by":"publisher","unstructured":"Rosenthal T, Gavras I. Angiotensin inhibition and malignancies: a review. J Hum Hypertens. 2009;23(10):623\u201335. https:\/\/doi.org\/10.1038\/jhh.2009.21 . Epub Apr 2","DOI":"10.1038\/jhh.2009.21"},{"issue":"9","key":"5493_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2174\/1381612033455396","volume":"9","author":"A Molteni","year":"2003","unstructured":"Molteni A, Ward WF, Ts'ao CH, Taylor J, Small W Jr, Brizio-Molteni L, et al. Cytostatic properties of some angiotensin I converting enzyme inhibitors and of angiotensin II type I receptor antagonists. Curr Pharm Des. 2003;9(9):751\u201361.","journal-title":"Curr Pharm Des"},{"key":"5493_CR24","first-page":"1","volume":"2","author":"PJ Fitzgerald","year":"2010","unstructured":"Fitzgerald PJ. Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer. Clin Epidemiol. 2010;2:1\u20133.","journal-title":"Clin Epidemiol"},{"issue":"2","key":"5493_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ijc.24063","volume":"124","author":"PJ Fitzgerald","year":"2009","unstructured":"Fitzgerald PJ. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer. 2009;124(2):257\u201363. https:\/\/doi.org\/10.1002\/ijc.24063 .","journal-title":"Int J Cancer"},{"issue":"7","key":"5493_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.18632\/oncotarget.101009","volume":"1","author":"DG Powe","year":"2010","unstructured":"Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628\u201338. https:\/\/doi.org\/10.18632\/oncotarget.101009 .","journal-title":"Oncotarget"},{"issue":"1","key":"5493_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.30717","volume":"141","author":"L Jansen","year":"2017","unstructured":"Jansen L, Weberpals J, Kuiper JG, Vissers PAJ, Wolkewitz M, Hoffmeister M, et al. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: results from a population-based study. Int J Cancer. 2017;141(1):62\u201371. https:\/\/doi.org\/10.1002\/ijc.30717 .","journal-title":"Int J Cancer"},{"issue":"5","key":"5493_CR28","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1593\/tlo.13346","volume":"6","author":"DR Engineer","year":"2013","unstructured":"Engineer DR, Burney BO, Hayes TG, Garcia JM. Exposure to ACEI\/ARB and beta-blockers is associated with improved survival and decreased tumor progression and hospitalizations in patients with advanced Colon Cancer. Transl Oncol. 2013;6(5):539\u201345 eCollection 2013.","journal-title":"Transl Oncol"},{"issue":"3","key":"5493_CR29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/000313480707300307","volume":"73","author":"JH Heinzerling","year":"2007","unstructured":"Heinzerling JH, Anthony T, Livingston EH, Huerta S. Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. Am Surg. 2007;73(3):230\u20138.","journal-title":"Am Surg"},{"issue":"11 Suppl","key":"5493_CR30","doi-asserted-by":"publisher","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","volume":"131","author":"E Giovannucci","year":"2001","unstructured":"Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001;131(11 Suppl):3109S\u201320S. https:\/\/doi.org\/10.1093\/jn\/131.11.3109S .","journal-title":"J Nutr"},{"key":"5493_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-60327-492-0_3","volume":"472","author":"AM Fair","year":"2009","unstructured":"Fair AM, Montgomery K. Energy balance, physical activity, and cancer risk. Methods Mol Biol. 2009;472:57\u201388. https:\/\/doi.org\/10.1007\/978-1-60327-492-0_3 .","journal-title":"Methods Mol Biol"},{"issue":"1","key":"5493_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-199818010-00001","volume":"18","author":"LG Howes","year":"1998","unstructured":"Howes LG, Edwards CT. Calcium antagonists and cancer. Is there really a link? Drug Saf. 1998;18(1):1\u20137.","journal-title":"Drug Saf"},{"key":"5493_CR33","doi-asserted-by":"crossref","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981\u201397.","DOI":"10.1001\/jama.288.23.2981"},{"key":"5493_CR34","unstructured":"Health Care Systems Research Network Oakland, CA: Kaiser Permanente Division of Research (Northern California); 2015 [Available from: http:\/\/www.hcsrn.org\/en\/ ."},{"issue":"11","key":"5493_CR35","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10552-016-0808-4","volume":"27","author":"J Chubak","year":"2016","unstructured":"Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, et al. The Cancer research network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016;27(11):1315\u201323.","journal-title":"Cancer Causes Control"},{"issue":"1","key":"5493_CR36","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.13063\/2327-9214.1049","volume":"2","author":"TR Ross","year":"2014","unstructured":"Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC, Hart G, et al. The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS. 2014;2(1):1049.","journal-title":"EGEMS"},{"issue":"5","key":"5493_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"1","key":"5493_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","volume":"4","author":"L Emilsson","year":"2018","unstructured":"Emilsson L, Garcia-Albeniz X, Logan RW, Caniglia EC, Kalager M, Hernan MA. Examining Bias in studies of statin treatment and survival in patients with Cancer. JAMA Oncol. 2018;4(1):63\u201370.","journal-title":"JAMA Oncol"},{"key":"5493_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40885-016-0042-0","volume":"22","author":"N Jarari","year":"2015","unstructured":"Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2015;22:7.","journal-title":"Clin Hypertens"},{"issue":"9","key":"5493_CR40","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290\u2013314.","journal-title":"Cancer."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5493-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T01:20:58Z","timestamp":1607044858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5493"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5493-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received human subjects\u2019 approval from Kaiser Permanente Washington Health Research Institute Human Subjects Committee (to which Kaiser Permanente Colorado ceded) in compliance with the Helsinki Declaration. In accordance with federal research regulations (45 CFR 46, 45 CFR 160 & 164 [HIPAA]) and in state laws (RCW 70.02), participant data were collected under a waiver of consent because the research and use of the data involved no more than a minimal risk to the privacy of individuals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Onchee Yu reports receiving funding as a biostatistician from a research grant awarded to Kaiser Permanente Washington Health Research Institute from Bayer. Monica Fujii reports receiving funding from a research contracts awarded to Kaiser Permanente Washington Health Research Institute from Allergan, Bio Delivery Sciences, Collegium, Daiichi Sankyo, Depomed, Egalet, Endo, Janssen, Mallinckrodt, Pernix, Pfizer, Purdue, and West-Ward. Denise Boudreau reports receiving funding from research contracts awarded to Kaiser Permanente Washington Health Research Institute from Allergan, Bio Delivery Sciences, Collegium, Daiichi Sankyo, Depomed, Egalet, Endo, Janssen, Mallinckrodt, Pernix, Pfizer, Purdue, and West-Ward. All other authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"270"}}